The pattern and timing of disease recurrence in squamous cancer of the anus: Mature results from the NCRI ACT II trial.
David Sebag-Montefiore
No relevant relationships to disclose
Roger James
No relevant relationships to disclose
Helen Meadows
No relevant relationships to disclose
Rubina Begum
No relevant relationships to disclose
David Cunningham
Consultant or Advisory Role - Amgen (U); Roche (U)
Research Funding - Amgen; AstraZeneca; Roche
Expert Testimony - Amgen (U); Roche (U)
John Northover
No relevant relationships to disclose
Jonathan A. Ledermann
No relevant relationships to disclose
Sandra Beare
No relevant relationships to disclose
Latha Kadalayil
No relevant relationships to disclose
Robert Glynne-Jones
Research Funding - Roche